SOMERSET, N.J., June 27, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced its chief executive officer and president, Hadi Chaudhry, has been selected to join the prestigious Forbes Business Council. This renowned organization serves as a premier growth and networking platform for accomplished business owners and leaders on a global scale.
Chaudhry has been selected for the Forbes Business Council based on his extensive experience and proven track record. With a background in finance and information technology (IT), Chaudhry joined CareCloud in 2002 as the IT manager and steadily climbed the ranks to become CEO. Working closely with his mentor and CareCloud's founder and executive chairman, Mahmud Haq, Chaudhry has played a vital role in the company's growth and market leadership. His inclusion in the Forbes Business Council provides the opportunity to share his expertise, collaborate with other accomplished members, and contribute to business excellence.
“We are honored to welcome Mr. Hadi Chaudhry into the community,” said Scott Gerber, founder of Forbes Councils, the collective that includes Forbes Business Council. “Our mission with Forbes Councils is to bring together proven leaders from every industry, creating a curated, social capital-driven network that helps every member grow professionally and make an even greater impact on the business world.”
The Forbes Business Council consists of accomplished professionals across diverse industries who are renowned for their expertise, influence, and remarkable contributions. Membership in this exclusive council provides exceptional opportunities for leaders like Chaudhry to maximize their professional influence. Chaudhry will engage in private forums and members-only events, fostering connections and collaborations with esteemed local leaders. Additionally, he will have the privilege of working with a professional editorial team to contribute original business articles on Forbes.com, sharing his expert insights, and participating in published Q&A panels alongside fellow experts.
"I am truly honored and thrilled to have the opportunity to join the prestigious Forbes Business Council," said Chaudhry. "This recognition highlights the remarkable dedication and hard work demonstrated by the entire CareCloud team in revolutionizing healthcare technology and delivering cutting-edge solutions to our valued customers. I am eagerly looking forward to sharing our extensive expertise and making valuable contributions to the council's mission of driving business excellence and inspiring thought leadership."
To learn more about CareCloud’s comprehensive suite of technology-enabled services and solutions, visit carecloud.com/solutions.
About CareCloud
CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
Company Contact:
Bill Korn
Chief Strategy Officer
CareCloud
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$1.25 |
Daily Change: | -0.01 -0.79 |
Daily Volume: | 645,400 |
Market Cap: | US$20.320M |
April 07, 2025 April 02, 2025 March 26, 2025 March 13, 2025 January 28, 2025 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load